Endocrine Reviews 18 (6): 801-831
Copyright © 1997 by The Endocrine Society
Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions1
Sujatha Rajaram,
David J. Baylink and
Subburaman Mohan
Mineral Metabolism Laboratory (D.J.B., S.M.), Jerry L. Pettis
Memorial Veterans Administration Medical Center, Department of
Nutrition (S.R.), School of Public Health, Departments of Medicine,
Biochemistry, and Physiology, School of Medicine (D.J.B., S.M), Loma
Linda University, Loma Linda, California 92357
- I. Introduction
- II. Characteristics of the IGFBPs
- III. Target Cell Actions of the IGFBPs
- A. To modulate IGF actions
- B. To facilitate storage of IGFs in extracellular matrices
- C. To exert IGF-independent effects
- IV. IGF-IGFBP Complexes in Biological Fluids
- A. Serum
- B. Milk
- C. Urine
- D. Cerebrospinal fluid (CSF)
- E. Follicular fluid
- F. Amniotic fluid
- G. Lymph
- H. Seminal fluid
- I. Other biological fluids
- V. Assays for Circulating Levels of IGFBP
- A. Western ligand blotting
- B. Western immunoblotting
- C. RIA
- D. Immunoradiometric assay (IRMA)
- VI. Relative Distribution of IGFBPs in Serum
- VII. Regulation of Serum IGFBPs
- A. Physiological conditions
- B. Development and aging
- C. Hormonal effects: mechanisms
- D. Pathological conditions
- VIII. IGFBP Proteases in Circulation
- A. Proteases under normal conditions
- B. Pregnancy-associated proteases
- C. Proteases under catabolic and disease states
- IX. Endocrine Functions of IGFBPs in Serum
- A. To prevent insulin-like effects
- B. To increase the half-lives of IGFs
- C. To control the transport of IGFs from the vascular space
- X. Conclusions
Copyright © 1997 by The Endocrine Society